Discontinuation Cluster · SSRI
Prozac (Fluoxetine) Onsite Taper
Onsite fluoxetine (Prozac) taper using its long-half-life metabolite as a built-in bridge, augmented by full-spectrum iboga TA.
Generic name
Fluoxetine
Drug class
SSRI
Half-life class
long
Plasma half-life
≈ 1–4 days (parent), 4–16 days (norfluoxetine metabolite)
Typical dose range
10–80 mg/day
Onsite taper duration
14–21 days onsite (driven by metabolite clearance, not parent drug)
TA bridge
Iboga TA 50–150 mg BID for full bridge window
Quick Answer
Can I taper off Prozac (Fluoxetine) at MindScape?
Reviewed by Dr. Arellano, M.D. — May 2026
Withdrawal Profile
- Withdrawal is typically delayed and milder than short-half-life SSRIs
- Late-onset emotional blunting reversal — irritability, lability, vivid dreams
- Anxiety rebound 2–4 weeks after final dose
- GI distress, fatigue
Why It's Hard To Taper At Home
- Long norfluoxetine tail makes home-taper feel deceptively easy until the metabolite clears, then symptoms emerge weeks later.
- Patients often relapse at week 3–4 because they no longer associate symptoms with the discontinuation.
- Hyperbolic micro-dosing below 10 mg requires compounded preparation.
MindScape Onsite Protocol
- Direct discontinuation is feasible for many patients given the long norfluoxetine tail.
- Iboga TA bridge 50–150 mg BID for 14–21 days to cover the metabolite-clearance window.
- Continuous cardiac telemetry across the entire bridge.
- Magnesium pre-loading; electrolyte normalization before any flood-dose ibogaine HCl.
Day-By-Day Patient Experience
- Days 1–3: workup; immediate or 50% dose reduction.
- Days 4–14: TA bridge covers norfluoxetine clearance window.
- Days 15–21: emergent symptoms (if any) addressed under telemetry.
- Optional ibogaine HCl flood for eligible candidates.
Day-counts and step-cadences are illustrative ranges, not personal medical advice. Individual taper duration is determined onsite by the medical team after baseline workup.
Citations & Reading
- Horowitz MA, Taylor D. (2019). Lancet Psychiatry, 6(6), 538-546.
For the broader iboga-TA evidence base, see the 2026 evidence-base review and the onsite taper cohort methodology page.
Other SSRI taper guides
Zoloft (Sertraline)
Onsite sertraline (Zoloft) taper bridged with sub-psychoactive iboga total alkaloid under continuous cardiac telemetry.
Lexapro (Escitalopram)
Onsite escitalopram (Lexapro) taper bridged with sub-psychoactive iboga total alkaloid — eliminates brain zaps, dizziness, and emotional rebound.
Paxil (Paroxetine)
Onsite paroxetine (Paxil) taper — the SSRI most associated with severe discontinuation syndrome — bridged with full-spectrum iboga TA.